IGF‐1, a potent mitogen, promotes cell proliferation and survival while inhibiting apoptosis via PI3K/AKT/mammalian target of rapamycin (mTOR) and MAPK pathways, fostering tumor initiation and progression [105, 122, 123]. Here, AKT1 is linked to neoplasm.